Welcome to LookChem.com Sign In|Join Free
  • or
2-(4-benzoyloxy-benzyl)-malonic acid diethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

756488-28-5

Post Buying Request

756488-28-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

756488-28-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 756488-28-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,5,6,4,8 and 8 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 756488-28:
(8*7)+(7*5)+(6*6)+(5*4)+(4*8)+(3*8)+(2*2)+(1*8)=215
215 % 10 = 5
So 756488-28-5 is a valid CAS Registry Number.

756488-28-5Relevant academic research and scientific papers

Anodic benzylic C(sp3)-H amination: Unified access to pyrrolidines and piperidines

Herold, Sebastian,Bafaluy, Daniel,Mu?iz, Kilian

supporting information, p. 3191 - 3196 (2018/07/29)

An electrochemical aliphatic C-H amination strategy was developed to access the important heterocyclic motifs of pyrrolidines and piperidines within a uniform reaction protocol. The mechanism of this unprecedented C-H amination strategy involves anodic C-H activation to generate a benzylic cation, which is efficiently trapped by a nitrogen nucleophile. The applicability of the process is demonstrated for 40 examples comprising both 5- and 6-membered ring formations.

The β-glucuronyl-based prodrug strategy allows for its application on β-glucuronyl-platinum conjugates

Tromp, Reynier A.,Van Boom, Stella S.G.E.,Timmers, C. Marco,Van Zutphen, Steven,Van Der Marel, Gijsbert A.,Overkleeft, Herman S.,Van Boom, Jacques H.,Reedijk, Jan

, p. 4273 - 4276 (2007/10/03)

The use of platinum drugs in antitumour therapy is well established. An important drawback of these chemotherapeutics is the lack of selectivity for tumour cells, usually resulting in severe toxic side effects. A glucuronyl-platinum conjugate was designed and synthesised to test the compatibility of platinum compounds with β-glucuronidase-based prodrug therapy. Instantaneous cleavage of the β-glucuronic bond in the glucuronyl-platinum conjugate was observed upon addition of β-glucuronidase resulting in PtII(dach)(4-hydroxybenzylmalonate) and glucuronic acid.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 756488-28-5